Florbetapir is an amyloid ligand used in positron emission tomography (PET) proposed as a way of detecting those who have MCI who will progress to dementia. What is the evidence to use this ligand in PET as a routine test? how effective given the costs? ht
Florbetapir is an amyloid ligand used in positron emission tomography (PET) proposed as a way of detecting those who have MCI who will progress to dementia. What is the evidence to use this ligand in PET as a routine test? how effective given the costs? h
18F-PETの感度と特異度は各々67% (95% CI 30 to 93) と71% (95% CI 54 to 85) アルツハイマーあるいはMCIへのルーティン検査は懐疑的 https://t.co/kMoEruDWmF
RT @DominicTrepel: New Cochrane evidence: three reviews focusing on 18F PET imaging agents for early diagnosis of Alzheimers disease & othe…
New Cochrane evidence: three reviews focusing on 18F PET imaging agents for early diagnosis of Alzheimers disease & other dementias in people with mild cognitive impairment (MCI): (1) https://t.co/JdFIiL7I9m; (2) https://t.co/L65ADzOBsa; (3) https://t.
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneLibrary: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's…
RT @CochraneLibrary: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's…
New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's disease & other #dementias in people with mild cognitive impairment (MCI): (1) https://t.co/eGLMfFe58w; (2) https://t.co/7ZY1QJQqx2;
RT @CochraneAT: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's disease & other #dementias in people with mild cognitive impairment (MCI): (1) https://t.co/lxgu9pSD23; (2) https://t.co/nJlQfmP9JQ;
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other… https://t.co/EV3voZVBI5
18F-florbetapir PET scan for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment https://t.co/y0ynJMZpCl
18F-florbetapir PET scan for the early diagnosis of Alzheimer's disease dementia and other… https://t.co/Qh72IMKicn